CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of GlaxoSmithKline Biologicals' DTPa-IPV/Hib (Infanrix™-IPV+Hib) Vaccine in Healthy Korean Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01309646
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:29.833906+00:00
Published At: 2013-04-02T00:00:00+00:00
Record Updated At: 2019-11-27
Results Posted At: 2013-04-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Poliomyelitis", "Tetanus", "Acellular Pertussis", "Diphtheria", "Haemophilus Influenzae Type b"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-11-27"
protocolSection.identificationModule.nctId: "NCT01309646"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety of GlaxoSmithKline Biologicals\u0027 DTPa-IPV/Hib (Infanrix\u2122-IPV+Hib) Vaccine in Healthy Korean Infants"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2013-04-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.